Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity
- PMID: 8610467
- DOI: 10.1006/viro.1996.0209
Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity
Abstract
The large surface protein (L) of the enveloped hepatitis B virus (HBV) is myristylated at glycine 2. To investigate whether this fatty acid moiety is required for HBV infectivity we made use of a point mutant in which the myristyl acceptor was mutated to a nonfunctional alanine. The mutant virus and a wild-type control were expressed in a human hepatoma cell line by transfection of genomic DNA constructs. Comparable amounts of virions were secreted by both strains as measured by the endogenous polymerase activity of immunoprecipitated virions. The presentation of an N-terminal epitope of L on the virion surface was not influenced by the mutation. To test the infectivity of this mutant virus primary human hepatocytes were incubated with the media of transfected cells. The covalently circular closed HBV DNA molecules generated after infection were discriminated from the open circular DNA genomes of inoculated virions by a sensitive PCR-based technique. The experiments demonstrated that the wild type was infectious but not the myristate negative mutant. This reflects the phenotype of an homologous duck hepatitis B virus mutant although the N-terminal L protein domains of this virus and of HBV show no primary sequence homology.
Similar articles
-
Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.Virology. 1995 Nov 10;213(2):292-9. doi: 10.1006/viro.1995.0002. Virology. 1995. PMID: 7491754
-
A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.Virology. 1995 Oct 20;213(1):57-69. doi: 10.1006/viro.1995.1546. Virology. 1995. PMID: 7483279
-
Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.J Virol. 2001 Feb;75(3):1104-16. doi: 10.1128/JVI.75.3.1104-1116.2001. J Virol. 2001. PMID: 11152483 Free PMC article.
-
[Virion structure of hepatitis B virus].Nihon Rinsho. 2004 Aug;62 Suppl 8:8-11. Nihon Rinsho. 2004. PMID: 15453276 Review. Japanese. No abstract available.
-
Role of glycan processing in hepatitis B virus envelope protein trafficking.Adv Exp Med Biol. 1998;435:207-16. doi: 10.1007/978-1-4615-5383-0_20. Adv Exp Med Biol. 1998. PMID: 9498079 Review. No abstract available.
Cited by
-
Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.Cold Spring Harb Perspect Med. 2015 Aug 3;5(8):a021378. doi: 10.1101/cshperspect.a021378. Cold Spring Harb Perspect Med. 2015. PMID: 26238794 Free PMC article. Review.
-
Intracellular Trafficking of HBV Particles.Cells. 2020 Sep 2;9(9):2023. doi: 10.3390/cells9092023. Cells. 2020. PMID: 32887393 Free PMC article. Review.
-
Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.J Virol. 2007 Dec;81(23):13057-66. doi: 10.1128/JVI.01495-07. Epub 2007 Sep 26. J Virol. 2007. PMID: 17898062 Free PMC article.
-
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.J Virol. 2007 Jun;81(11):5841-9. doi: 10.1128/JVI.00096-07. Epub 2007 Mar 21. J Virol. 2007. PMID: 17376925 Free PMC article.
-
Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.Antiviral Res. 2018 Oct;158:185-198. doi: 10.1016/j.antiviral.2018.08.014. Epub 2018 Aug 24. Antiviral Res. 2018. PMID: 30145242 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources